everything to know about retatrutide Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation There's so much talk about

Injection-site reactions low single-digit incidence, mostly mild

We encourage you to consult with our healthcare specialists to determine if Ozempic or another GLP-1 receptor agonist is the best fit to enhance your health and overall well-being

Bringing this data to medical appointments enables more informed discussions with your healthcare provider about treatment adjustments

doi: 10.1186/s12933-022-01474-z Summary Keywords glucagon-like peptide-1, glucagon-like peptide-1 receptor agonist, cardiovascular diseases, major adverse cardiovascular events, diabetes mellitus Citation Ferhatbegovi L, Mri D and Maci-Dankovi A (2023) The benefits of GLP1 receptors in cardiovascular diseases

Farnesoid X receptor and bile salts are involved in transcriptional regulation of the gene encoding the human bile salt export pump